& Jun, H
This is highly speculative because: Oral bioavailability differs between species Route of administration affects systemic exposure Species differences in peptide metabolism and clearance are unknown Current Practice Patterns Current practice patterns from unregulated sources typically involve: Subcutaneous injection: 0.25-0.5 mg once or twice daily, administered near injection sites for localized effects or abdominally for systemic distribution
Potential side effects Possible side effects of supplementary l-carnitine include, but are not limited to: Gut disturbance: l-carnitine does not have an established upper intake level, although doses above 3g per day may cause nausea, vomiting, abdominal cramps and diarrhoea Coronary artery disease: some research suggests l-carnitine may be linked to an increased risk of coronary artery disease and heart failure, especially in men and those who eat meat
Results depend on starting skin tone, desired brightness level, and individual response
This decline in growth hormone levels is associated with various age-related symptoms such as weight gain, fatigue, and decreased muscle mass
Ipamorelin was designed to retain a strong effect on GH while eliminating these side effects which is why it is described as the "cleanest" GHRP and is often chosen for the first research protocols